US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

685.75

-15.2311-2.17%

Number of Gainers:61

Number of Losers:84

Number of Flat:9

PE:- -

High:703.53

Open:700.98

Low:685.46

Close:700.98

Volume:313.13M

Turnover:10.17B

Market Cap:479.55B

Float Cap:364.16B

Loading ...

Dermata Therapeutics Prices USD 3.4 Million Private Placement at USD 1.46 Per Share

Riskified Says May Flight Fraud Risk Rises 32% as Travel Scammers Mimic Legitimate Behavior

AppLovin Price Target Cut to $440.00/Share from $500.00 by Benchmark

Press Release: Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Mobix Labs - Guides Fiscal Q4 2026 Revenue of $1.40 Mln-$1.80 Mln

THOMSON REUTERS

Mobix Labs Forecasts Fiscal Q4 Revenue of $1.4 Million-$1.8 Million

Acurx Pharmaceuticals Receives FDA Conditional Acceptance and Uspto Trademark Allowance for the Company's Brand Name for Ibezapolstat

THOMSON REUTERS

Benchmark Adjusts Price Target on AppLovin to $440 From $500, Keeps Buy Rating

MT Newswires Live

Applovin Corporation : Benchmark Cuts Target Price to $440 from $500

THOMSON REUTERS

Morgan Stanley Adjusts PT on Recursion Pharmaceuticals to $5.30 From $5.50, Keeps Equalweight Rating

MT Newswires Live

Global-e Online price target raised to $49 from $45 at Goldman Sachs

Sprinklr appoints Jordi Ribas to board of directors

Biomea Fusion doses first patient in OPAL study

Valerio Therapeutics Nears Signing of €30 Million Etherna Acquisition

Cboe data shows mixed options sentiment in Oklo Inc with shares up 0.25%

After Selling VIZIO to Walmart for $2.3 Billion, Founder William Wang Readies for a Potential Third Venture

Press Release: Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition

Coinbase CEO Envisions Cryptocurrency as the Ideal Currency for AI Financial Systems

Unicycive Therapeutics Posts Corporate Presentation on Kidney Disease Drug Pipeline, Led by OLC for Dialysis Hyperphosphatemia

Global-E Online (GLBE) Following Raised 2026 Guidance And Strong Results Still Looks Undervalued

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4539/news?page=24"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":685.7458,"timestamp":1787601599999,"preClose":700.9769,"halted":0,"volume":313126904,"delay":0,"changeRate":-0.021728,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-15.23114,"latestTime":"08-24 16:00:00 EDT","open":700.9787,"high":703.53143,"low":685.4632,"amount":10165204650.256977,"amplitude":0.025776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.245326,"peRate":150.969108,"turnoverRate":0.024191,"increases":61,"decrements":84,"flats":6,"marketCap":479546114433.625,"floatMarketCap":364158638649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":703.53143,"amplitude":0.025776,"preClose":700.9769,"low":685.4632,"pbRate":"5.245326","latestPrice":685.7458,"volume":313126904,"delay":0,"open":700.9787,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":666.772,"twentyDayClose":702.6321,"sixtyDayClose":754.549,"secType":"PLATE","market":"US","turnoverRate":0.024191,"peRate":150.969108,"marketCap":479546114433.625,"floatMarketCap":364158638649,"timestamp":1787601599999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":61,"down":84,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:24,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660487799","title":"Dermata Therapeutics Prices USD 3.4 Million Private Placement at USD 1.46 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487799?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969849,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics prices USD 3.4 million private placement at USD 1.46 per shareDermata Therapeutics priced a private placement at-the-market under Nasdaq rules, issuing 2,293,608 common shares or ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL8q9Vc9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","DRMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660725487","title":"Riskified Says May Flight Fraud Risk Rises 32% as Travel Scammers Mimic Legitimate Behavior","url":"https://stock-news.laohu8.com/highlight/detail?id=2660725487","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660725487?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969846,"startTime":"0","endTime":"0","summary":"Riskified says May flight fraud risk rises 32% as travel scammers mimic legitimate behaviorRiskified reported flight fraud risk rose through the first five months of 2026, with May up 32% year over ye","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL3wrvlH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","RSKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487745","title":"AppLovin Price Target Cut to $440.00/Share from $500.00 by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487745","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487745?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:28","pubTimestamp":1786969680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APP/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APP","BK4585","LU2063271972.USD","LU2087625088.SGD","BK4539","APPX","LU2360106780.USD","LU2290526834.HKD","LU0154236417.USD","IE00B894F039.SGD","BK4023","IE00BZ9MQY76.HKD","BK4608","LU1861215975.USD","BK4613","LU0056508442.USD","LU1861220033.SGD","XDAT","LU2250418816.HKD","BK4588","IE00B19Z9Z06.USD","LU0353189763.USD","LU2360107168.USD","IE00B19Z9P08.USD","LU0353189680.USD","CLOD","LU0097036916.USD","LU1852331112.SGD","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487499","title":"Press Release: Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487499","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487499?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:20","pubTimestamp":1786969200,"startTime":"0","endTime":"0","summary":"Differentiated Autologous PRP Remains Well-Positioned for Attractive Long-Term GrowthHOUSTON, Aug. 17, 2026  -- Nuo Therapeutics, Inc.  , a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care, announced financial results for the second quarter ended June 30, 2026 and provided an operational and business update.Second Quarter and First Half 2026 Financial Summary-- Total revenues of approximately $1.77 million and $3.07 million for the. second quarter 2026 and first half of 2026, respectively, were each up in. -- Total 2Q product revenues increased 38% sequentially versus 1Q 2026 with. Aurix branded product revenues increasing in excess of 30% sequentially. -- Second quarter net operating loss of approximately $167,000 improved by. approximately $280,000 compared to the first quarter of 2026. -- Amended and restated loan agreement with an interim funding of $675,000. and with $325,000 remaining available under commitm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","AURX","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487862","title":"Mobix Labs - Guides Fiscal Q4 2026 Revenue of $1.40 Mln-$1.80 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487862?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:06","pubTimestamp":1786968406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MOBX","BK4141","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660248279","title":"Mobix Labs Forecasts Fiscal Q4 Revenue of $1.4 Million-$1.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248279","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660248279?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:02","pubTimestamp":1786968143,"startTime":"0","endTime":"0","summary":"Mobix Labs forecasts fiscal Q4 revenue of $1.4 million-$1.8 millionMobix Labs guided fiscal Q4 2026 revenue of $1.4 million to $1.8 million.Midpoint implies about 100% sequential growth versus the pri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9xjBgK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOBX","BK4539","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482224","title":"Acurx Pharmaceuticals Receives FDA Conditional Acceptance and Uspto Trademark Allowance for the Company's Brand Name for Ibezapolstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482224","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482224?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:01","pubTimestamp":1786968060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUA4R5JMM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660818214","title":"Benchmark Adjusts Price Target on AppLovin to $440 From $500, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660818214","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660818214?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:20","pubTimestamp":1786962005,"startTime":"0","endTime":"0","summary":"AppLovin (APP) has an average rating of buy and mean price target of $550.93, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1852331112.SGD","LU2087625088.SGD","IE00BZ9MQY76.HKD","LU0154236417.USD","LU2250418816.HKD","BK4585","APP","APPX","LU1861220033.SGD","BK4613","XDAT","CLOD","BK4588","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0353189763.USD","BK4539","LU0353189680.USD","LU0097036916.USD","LU2290526834.HKD","LU2360106780.USD","BK4023","IE00B19Z9Z06.USD","LU2360107168.USD","BK4608","LU1861215975.USD","BK4009","LU0056508442.USD","LU2063271972.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660048996","title":"Applovin Corporation : Benchmark Cuts Target Price to $440 from $500","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048996","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660048996?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:01","pubTimestamp":1786960872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E04H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861215975.USD","LU2360107168.USD","LU0097036916.USD","BK4608","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU2360106780.USD","XDAT","BK4588","LU2250418816.HKD","LU2290526834.HKD","LU0154236417.USD","LU2063271972.USD","APPX","LU1861220033.SGD","LU0056508442.USD","LU2087625088.SGD","BK4009","BK4613","BK4539","IE00B19Z9P08.USD","LU1852331112.SGD","BK4023","CLOD","LU0353189763.USD","LU0353189680.USD","BK4585","IE00BZ9MQY76.HKD","APP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489363","title":"Morgan Stanley Adjusts PT on Recursion Pharmaceuticals to $5.30 From $5.50, Keeps Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489363","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489363?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:54","pubTimestamp":1786960445,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals (RXRX) has an average rating of overweight and mean price target of $7.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4611","BK4609","RXRX","BK4139","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660485834","title":"Global-e Online price target raised to $49 from $45 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2660485834","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660485834?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:40","pubTimestamp":1786956037,"startTime":"0","endTime":"0","summary":"Goldman Sachs raised the firm’s price target on Global-e Online (GLBE) to $49 from $45 and keeps a Buy rating on the shares. Shares underperformed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/global-e-online-price-target-raised-to-49-from-45-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/global-e-online-price-target-raised-to-49-from-45-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4585","GLBE","BK4122","BK4220","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488426","title":"Sprinklr appoints Jordi Ribas to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488426","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488426?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:01","pubTimestamp":1786953718,"startTime":"0","endTime":"0","summary":"Sprinklr (CXM) appointed Jordi Ribas, Ph.D., to its Board of Directors, effective August 17. Jordi currently serves as President of Search & AI at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sprinklr-appoints-jordi-ribas-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sprinklr-appoints-jordi-ribas-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTY","BK4539","AIPO","AGIX","QTOC","BK4023","CHAT","CXM","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660359488","title":"Biomea Fusion doses first patient in OPAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2660359488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660359488?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:38","pubTimestamp":1786952287,"startTime":"0","endTime":"0","summary":"Biomea Fusion (BMEA) announced that the first participant has been dosed in a new arm of the ongoing platform research study, Investigating and Opt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-doses-first-patient-in-opal-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-doses-first-patient-in-opal-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPAL","BK4539","BK4585","BK4139","BK4138","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660001091","title":"Valerio Therapeutics Nears Signing of €30 Million Etherna Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660001091","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660001091?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:21","pubTimestamp":1786951308,"startTime":"0","endTime":"0","summary":"An update from Valerio Therapeutics ( ($FR:ALVIO) ) is now available. Valerio Therapeutics has provided an update on its project to acquire 100% of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/valerio-therapeutics-nears-signing-of-e30-million-etherna-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/valerio-therapeutics-nears-signing-of-e30-million-etherna-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660100456","title":"Cboe data shows mixed options sentiment in Oklo Inc with shares up 0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660100456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660100456?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:21","pubTimestamp":1786951267,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Oklo Inc (OKLO), with shares up 12c, or 0.25%, near $45.24. Options volume roughly in line with average ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-oklo-inc-with-shares-up-0-25-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-oklo-inc-with-shares-up-0-25-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKLL","NLR","OKLS","BK4539","BK4081","URAN","OKLO","BK4606","URA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101773025","title":"After Selling VIZIO to Walmart for $2.3 Billion, Founder William Wang Readies for a Potential Third Venture","url":"https://stock-news.laohu8.com/highlight/detail?id=1101773025","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101773025?lang=en_us&edition=fundamental","pubTime":"2026-08-17 14:42","pubTimestamp":1786948934,"startTime":"0","endTime":"0","summary":"William Wang, the founder of smart TV platform company VIZIO, describes the company as his child that has now matured and grown up. Born in Taiwan, Wang immigrated to the United States at age 12 and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000819398.USD","LU2746668974.SGD","LU0289960550.SGD","BK4078","LU2592432038.USD","LU1066051225.USD","LU2430703178.SGD","LU0553294199.USD","BK4597","TRUO","LU1066051811.HKD","LU1116320737.USD","LU0149725797.USD","IE0001KFT4U8.USD","LU2471134796.USD","BK4532","LU1814569148.SGD","LU0949170772.SGD","LU0417517546.SGD","LU1035773651.USD","LU0265550359.USD","BK4534","LU0211328371.USD","UGE","LU0265550946.USD","LU0238689110.USD","LU0353189763.USD","BK4588","BK4504","LU2471134952.CNY","LU1430594728.SGD","BK4581","LU2505996509.AUD","LU2097829019.USD","LU1804176565.USD","LU0661504455.SGD","LU1066053197.SGD","LU2430703095.HKD","LU0353189680.USD","LU1674673691.USD","LU1267930490.SGD","BK4596","LU0096362180.USD","LU0957791311.USD","LU1366192091.USD","GB00BDT5M118.USD","LU1116320901.HKD","LU2360032135.SGD","LU2361044949.HKD","LU2087625088.SGD","BK4550","LU0545039389.USD","BK4533","BK4585","LU0175139822.USD","LU2125154778.USD","LU0738911758.USD","LU1674673428.USD","LU0640476718.USD","LU2125154935.USD","LU1066051498.USD","LU1069347547.HKD","FSTA","LU1585245621.USD","LU1280957306.USD","LU0314104364.USD","IE000M9KFDE8.USD","LU0061474960.USD","LU2746668461.USD","LU1003077747.HKD","IE0034235188.USD","LU0310799852.SGD","LU0256863811.USD","LU2361045086.USD","XLP","LU0211327993.USD","LU2461242641.AUD","LU2750360641.GBP","LU2750360997.AUD","LU2430703251.USD","RTH","LU2381873111.SGD","LU2264538146.SGD","LU2265009873.SGD","BK4155","LU0256863902.USD","LU1815333072.USD","LU1988902786.USD","VZIO","WMT","LU2505996681.GBP","LU1064131342.USD","BK4539","WMTI","LU2361044865.SGD","LU2471134879.HKD","LU2471134523.USD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660027881","title":"Press Release: Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660027881","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660027881?lang=en_us&edition=fundamental","pubTime":"2026-08-17 14:00","pubTimestamp":1786946400,"startTime":"0","endTime":"0","summary":"VILLEJUIF, France--(BUSINESS WIRE)--August 17, 2026--Regulatory News:Valerio Therapeutics (FR0010095596 - ALVIO), a biotechnology company pioneering next-generation precision-guided RNA therapeutics (","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRGS","BK4097","BK4007","LENZ","BK4139","BK4539","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132291505","title":"Coinbase CEO Envisions Cryptocurrency as the Ideal Currency for AI Financial Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=1132291505","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132291505?lang=en_us&edition=fundamental","pubTime":"2026-08-17 11:22","pubTimestamp":1786936929,"startTime":"0","endTime":"0","summary":"According to WoofunAI, Coinbase Global, Inc. CEO Brian Armstrong has formally introduced the concept of \"AiFi,\" establishing cryptocurrency as a cornerstone of AI-agent-driven financial systems and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","HECO","CRY","LU2360107671.USD","BITW","BITQ","FIAT","CONL","BK4516","ARKB","QBF","CBTA","SBIT","BFAP","BTCL","DFII","CBXJ","BITY","ARTY","COYY","LU1861558580.USD","XBTY","BK4112","TXXH","BTCI","NCIQ","CBTO","CBTY","159940","BITO","FBTC","QTOC","FDIG","GBTC","CBOJ","BTRN","STCE","BITX","BAGY","IBLC","CBXA","LFGY","BPI","LU1861220207.SGD","AGIX","IBIT","CBOY","DIME","BLCK","BCCC","HODL","BTF","BETE","BK4585","CBXO","FINX","BTC","BLOX","BLOK","BRRR","ETTY","BTCW","COIW","TEKX","BK4588","CBOA","BTCO","CONY","AIPO","LU1861559042.SGD","BK4551","BK4595","BTFX","LU1861217088.USD","BK4594","CHAT","BFJL","DAPP","COII","BK4082","DEFI","CRPT","BK4601","BKCH","CBXY","VTHR","COIN","COIA","BITB","BTCC","ICOI","BTCZ","BK4554","CBOO","CBTJ","COIG","CONX","BK4600","MAXI","YBTC","EZBC","GDLC","BK4539","BITI","COIO","BITU","CONI","BETH","BK4596","MNRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660007106","title":"Unicycive Therapeutics Posts Corporate Presentation on Kidney Disease Drug Pipeline, Led by OLC for Dialysis Hyperphosphatemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2660007106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660007106?lang=en_us&edition=fundamental","pubTime":"2026-08-17 09:58","pubTimestamp":1786931915,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics posts corporate presentation on kidney disease drug pipeline, led by OLC for dialysis hyperphosphatemiaUnicycive outlined plans to resubmit its NDA for oxylanthanum carbonate, a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLbkxRdV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660384109","title":"Global-E Online (GLBE) Following Raised 2026 Guidance And Strong Results Still Looks Undervalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2660384109","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660384109?lang=en_us&edition=fundamental","pubTime":"2026-08-17 09:27","pubTimestamp":1786930048,"startTime":"0","endTime":"0","summary":"Why Global-E Online Stock Is Back In Focus After Fresh Guidance\nGlobal-E Online (GLBE) moved back onto investor radars after raising full year 2026 revenue guidance to a range of $1,305 million to $1,355 million, alongside detailed second quarter 2026 earnings results.\nSee our latest analysis for Global-E Online.\nGlobal-E Online's raised full year guidance and strong second quarter figures have coincided with a 46.73% 90 day share price return and a 37.49% 1 year total shareholder return,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice2-main-header/1585186866479","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice2-main-header/1585186866479"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-glbe/global-e-online/news/global-e-online-glbe-following-raised-2026-guidance-and-stro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-glbe/global-e-online/news/global-e-online-glbe-following-raised-2026-guidance-and-stro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4122","BK4539","BK4588","GLBE","BK4585","BK4220"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":24,"totalSize":1080,"code":"91000000","status":"200"}]}}